Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy

A Prospective Natural-History Study of Coronary Atherosclerosis

(2011) Gregg W. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lipoprotein apheresis

(2010) Gilbert R Thompson   CURRENT OPINION IN LIPIDOLOGY

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

(2010) Frederick J Raal et al.   LANCET

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

Other Therapies for Reducing Low-Density Lipoprotein Cholesterol: Medications in Development

(2009) Evan A. Stein   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Vascular Calcifications in Homozygote Familial Hypercholesterolemia

(2008) Z. Awan et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study

(2008) A. Neil et al.   EUROPEAN HEART JOURNAL

A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia

(2007) A. David Marais et al.   ATHEROSCLEROSIS